Nunzia Pharmaceutical Corporation
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Com… Read more
Nunzia Pharmaceutical Corporation (NUNZ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2022: 0.591x
Based on the latest financial reports, Nunzia Pharmaceutical Corporation (NUNZ) has a cash flow conversion efficiency ratio of 0.591x as of September 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-113.09K) by net assets ($-191.32K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nunzia Pharmaceutical Corporation - Cash Flow Conversion Efficiency Trend (2017–2021)
This chart illustrates how Nunzia Pharmaceutical Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nunzia Pharmaceutical Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nunzia Pharmaceutical Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OMNIA HOLD (OHZ.SG)
STU:OHZ
|
N/A |
|
Bruton Limited
OL:BRUT
|
-0.003x |
|
Pomvom
TA:PMVM
|
-0.406x |
|
Trillium Acquisition Corp
V:TCK-P
|
-0.044x |
|
BRIGHTSPIRE CAP. CL.A-01
F:41W0
|
N/A |
|
PRESS CORPORATION LIMITED
MSE:PCL
|
N/A |
|
Ashtead Technology Holdings PLC
LSE:AT
|
0.153x |
|
LIBERTY INT QVC-A (LB3A.SG)
STU:LB3A
|
0.042x |
Annual Cash Flow Conversion Efficiency for Nunzia Pharmaceutical Corporation (2017–2021)
The table below shows the annual cash flow conversion efficiency of Nunzia Pharmaceutical Corporation from 2017 to 2021.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | $-94.17K | $-86.78K | 0.921x | +3.87% |
| 2020-12-31 | $-36.40K | $-32.29K | 0.887x | +427.01% |
| 2019-12-31 | $-22.57K | $-3.80K | 0.168x | +1202.18% |
| 2018-12-31 | $-293.97K | $-3.80K | 0.013x | -8.36% |
| 2017-12-31 | $-269.39K | $-3.80K | 0.014x | -- |